Biogen | BIIB - 应收帐款人



金融业
股票价格
USD
资产
USD 29.48B
现金及等价物
USD 3.38B
销售成本
USD 797.5M
流动资产
USD 9.19B
流动负债
USD 3B
债务
USD 6.56B
EBIT
USD 514.3M
EBITDA
USD 649.7M
员工
7.61K
EPS每股收益
USD 3.57
股本和储备
USD 18.65B
销售毛利
USD 1.82B
债务利息支出
USD 72.6M
利息收入
USD 37.9M
贷款资金
USD 6.29B
市值
USD 28.85B
净收入
USD 319.5M
营业费用
USD 1.96B
营业利润
USD 514.3M
普通股股本
USD 146.7M
PE价格收益
13.7
税前利润
USD 377.7M
销售收入
USD 2.25B
销售和管理费用
USD 554.3M
股票
USD 1.95B
贸易债权人
USD 358.5M
应收帐款人
USD 1.79B


应收帐款人 更改 日
AbbVie USD 12.59B 180M 2025-12
Acadia Pharmaceuticals USD 148.38M 153K 2026-03
ALKERMES USD 407.63M 73.6M 2026-03
Amgen USD 9.14B 432M 2026-03
Bayer EUR 18.55B 4.36B 2026-03
Biogen USD 1.79B 76.6M 2026-03
BioMarin Pharmaceutical USD 903.91M 4.3M 2026-03
Bristol-Myers Squibb USD 14.36B 164M 2026-03
Eli Lilly USD 21.18B 1.02B 2026-03
Esperion Therapeutics USD 140.19M 21.21M 2025-12
Gilead Sciences USD 4.74B 172M 2026-03
Incyte USD 1.05B 27.09M 2026-03
Merck USD 11.78B 345M 2025-12
Moderna USD 71M 113M 2026-03
Neurocrine Biosciences USD 768.1M 81.3M 2026-03
Novartis USD 9.6B 2.69B 2026-03
Pfizer USD 16.17B 332M 2026-03
PTC Therapeutics USD 181.62M 21.45M 2025-12
Puma Biotechnology USD 28.1M 3.52M 2024-06
Regeneron Pharmaceuticals USD 5.73B 10.1M 2026-03
Sangamo BioSciences USD 581K 110K 2024-06
Sanofi EUR 482M 85M 2026-03
Sanofi EUR 397M 186.13M 2025-12
Sarepta Therapeutics USD 547.91M 149.68M 2026-03
Teva Pharmaceutical Industries USD 3.39B 316M 2026-03
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
United Therapeutics USD 312M 38.2M 2026-03
Vertex Pharmaceuticals USD 2B 56.7M 2026-03